| Primary |
| Product Used For Unknown Indication |
50.0% |
| Drug Use For Unknown Indication |
17.2% |
| Drug Exposure During Pregnancy |
10.4% |
| Epilepsy |
9.4% |
| Convulsion |
2.6% |
| Maternal Exposure Timing Unspecified |
2.1% |
| Bipolar Disorder |
1.8% |
| Schizophrenia |
1.3% |
| Affective Disorder |
0.7% |
| Mania |
0.7% |
| Petit Mal Epilepsy |
0.7% |
| Depression |
0.4% |
| Migraine |
0.4% |
| Agitation |
0.3% |
| Cardiac Disorder |
0.3% |
| Convulsion Prophylaxis |
0.3% |
| Grand Mal Convulsion |
0.3% |
| Psychotic Disorder |
0.3% |
| Urinary Tract Infection |
0.3% |
| Anxiety |
0.2% |
|
| Foetal Anticonvulsant Syndrome |
37.3% |
| Convulsion |
7.4% |
| Drug Interaction |
6.6% |
| Tremor |
5.7% |
| Weight Increased |
4.5% |
| Somnolence |
3.7% |
| Speech Disorder Developmental |
3.7% |
| Drug Ineffective |
3.3% |
| Epilepsy |
3.3% |
| Foetal Exposure During Pregnancy |
2.9% |
| Learning Disorder |
2.9% |
| Thrombocytopenia |
2.9% |
| Unevaluable Event |
2.5% |
| Vomiting |
2.5% |
| Drug Level Decreased |
2.0% |
| Hyponatraemia |
2.0% |
| Treatment Noncompliance |
2.0% |
| Grand Mal Convulsion |
1.6% |
| Mania |
1.6% |
| Off Label Use |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
36.2% |
| Drug Use For Unknown Indication |
23.3% |
| Epilepsy |
8.9% |
| Schizophrenia |
5.0% |
| Convulsion |
3.9% |
| Bipolar Disorder |
3.4% |
| Urinary Tract Infection |
2.7% |
| Aggression |
2.6% |
| Depression |
2.1% |
| Grand Mal Convulsion |
1.5% |
| Petit Mal Epilepsy |
1.5% |
| Affective Disorder |
1.3% |
| Drug Exposure During Pregnancy |
1.3% |
| Extrapyramidal Disorder |
1.1% |
| Pneumonia |
1.1% |
| Thrombosis Prophylaxis |
1.0% |
| Blood Cholesterol Increased |
0.9% |
| Pain |
0.9% |
| Convulsion Prophylaxis |
0.8% |
| Depressed Mood |
0.8% |
|
| Weight Increased |
11.4% |
| Somnolence |
6.4% |
| Vomiting |
6.4% |
| White Blood Cell Count Decreased |
6.4% |
| Convulsion |
5.7% |
| Epilepsy |
5.7% |
| Pyloric Stenosis |
5.0% |
| Sinusitis |
5.0% |
| Tremor |
5.0% |
| Wound |
5.0% |
| Drug Interaction |
4.3% |
| Mania |
4.3% |
| Neutropenia |
4.3% |
| Syncope |
4.3% |
| Inappropriate Schedule Of Drug Administration |
3.6% |
| Intention Tremor |
3.6% |
| International Normalised Ratio Increased |
3.6% |
| Toxicity To Various Agents |
3.6% |
| Treatment Noncompliance |
3.6% |
| Atrial Fibrillation |
2.9% |
|
| Concomitant |
| Epilepsy |
23.9% |
| Schizophrenia |
13.7% |
| Drug Use For Unknown Indication |
12.1% |
| Product Used For Unknown Indication |
8.2% |
| Depression |
6.5% |
| Convulsion |
4.8% |
| Bipolar Disorder |
3.8% |
| Hypertension |
3.8% |
| Psychotic Disorder |
3.7% |
| Hiv Infection |
3.5% |
| Affective Disorder |
2.8% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Pain |
1.7% |
| Schizoaffective Disorder |
1.7% |
| Anxiety |
1.4% |
| Glioblastoma Multiforme |
1.4% |
| Constipation |
1.3% |
| Obesity |
1.3% |
| Headache |
1.2% |
| Hypothyroidism |
1.2% |
|
| Epilepsy |
10.4% |
| Convulsion |
7.7% |
| Vomiting |
7.7% |
| White Blood Cell Count Decreased |
6.6% |
| White Blood Cell Count Increased |
6.6% |
| Death |
6.0% |
| Somnolence |
5.5% |
| Thrombocytopenia |
4.9% |
| Weight Increased |
4.9% |
| Schizophrenia |
4.4% |
| Tremor |
4.4% |
| Suicidal Ideation |
3.8% |
| Urinary Incontinence |
3.8% |
| Urinary Tract Infection |
3.8% |
| Weight Decreased |
3.8% |
| Product Quality Issue |
3.3% |
| Speech Disorder |
3.3% |
| Tachycardia |
3.3% |
| Wheezing |
3.3% |
| Neutropenia |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
26.1% |
| Product Used For Unknown Indication |
9.9% |
| Bipolar Disorder |
7.2% |
| Epilepsy |
7.2% |
| Schizophrenia |
7.2% |
| Affective Disorder |
5.4% |
| Insomnia |
5.4% |
| Psychotic Disorder |
5.4% |
| Convulsion |
3.6% |
| Depression |
3.6% |
| Lower Respiratory Tract Infection |
3.6% |
| Acquired Immunodeficiency Syndrome |
2.7% |
| Analgesia |
1.8% |
| Anxiety |
1.8% |
| Blood Cholesterol |
1.8% |
| Blood Pressure |
1.8% |
| Smoking Cessation Therapy |
1.8% |
| Thyroid Disorder |
1.8% |
| Abdominal Pain Upper |
0.9% |
| Agitation |
0.9% |
|
| Drug Interaction |
28.6% |
| Wheezing |
21.4% |
| Drug Level Below Therapeutic |
7.1% |
| Haematemesis |
7.1% |
| Injury |
7.1% |
| Tremor |
7.1% |
| White Blood Cell Count Decreased |
7.1% |
| Drug Level Increased |
3.6% |
| Extrapyramidal Disorder |
3.6% |
| Multi-organ Failure |
3.6% |
| Toxicity To Various Agents |
3.6% |
|
